Multi-scale optoacoustic molecular imaging of brain diseases.
Daniel RazanskyJan KlohsRuiqing NiPublished in: European journal of nuclear medicine and molecular imaging (2021)
The ability to non-invasively visualize endogenous chromophores and exogenous probes and sensors across the entire rodent brain with the high spatial and temporal resolution has empowered optoacoustic imaging modalities with unprecedented capacities for interrogating the brain under physiological and diseased conditions. This has rapidly transformed optoacoustic microscopy (OAM) and multi-spectral optoacoustic tomography (MSOT) into emerging research tools to study animal models of brain diseases. In this review, we describe the principles of optoacoustic imaging and showcase recent technical advances that enable high-resolution real-time brain observations in preclinical models. In addition, advanced molecular probe designs allow for efficient visualization of pathophysiological processes playing a central role in a variety of neurodegenerative diseases, brain tumors, and stroke. We describe outstanding challenges in optoacoustic imaging methodologies and propose a future outlook.
Keyphrases
- high resolution
- resting state
- white matter
- cerebral ischemia
- functional connectivity
- single molecule
- optical coherence tomography
- mass spectrometry
- magnetic resonance imaging
- stem cells
- atrial fibrillation
- multiple sclerosis
- fluorescence imaging
- brain injury
- high throughput
- mesenchymal stem cells
- quantum dots
- single cell
- liquid chromatography
- finite element analysis